Milestone Pharmaceuticals Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
MIST Nasdaq 2830 www.milestonepharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes - Aug 27th, 2026 6:00 am
Milestone Pharmaceuticals shares rise as first patient enters Phase 3 AFib trial - Aug 21st, 2026 7:28 am
Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR) - Aug 21st, 2026 6:00 am
Milestone Pharmaceuticals Inc. Q2 2026 Earnings Call Summary - Aug 12th, 2026 7:39 pm
Milestone Pharmaceuticals Q2 Earnings Call Highlights - Aug 12th, 2026 9:04 am
Milestone Pharmaceuticals (MIST) Reports Q2 Loss, Lags Revenue Estimates - Aug 12th, 2026 6:25 am
Milestone Pharmaceuticals shares tumble after Q2 earnings miss - Aug 12th, 2026 6:04 am
Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update - Aug 12th, 2026 5:08 am
Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026 - Aug 4th, 2026 2:01 pm
After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Milestone Pharmaceuticals (MIST) - Jul 29th, 2026 7:35 am
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jul 2nd, 2026 7:30 pm
Milestone (MIST) Q1 2026 Earnings Transcript - Jun 1st, 2026 8:31 am
Paroxysmal Supraventricular Tachycardia Market Analysis Report 2026-2036, Profiles of Leading Players - Medtronic, Boston Scientific, Abbott Laboratories, Milestone Pharmaceuticals, Sanofi, Pfizer - May 21st, 2026 7:00 am
Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) Path To Profitability - May 15th, 2026 4:49 am
Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ - May 14th, 2026 6:30 am
Milestone Pharmaceuticals Inc. Q1 2026 Earnings Call Summary - May 13th, 2026 6:44 pm
Milestone Pharmaceuticals Inc (MIST) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ... - May 13th, 2026 5:00 pm